Cargando…
Discovery of an effective anti-inflammatory agent for inhibiting the activation of NF-κB
In this study, based on the effect of compounds on the activation of NF-κB and NO release, compound 51 was discovered as the best one with NO release inhibition IC(50) value was 3.1 ± 1.1 μM and NF-κB activity inhibition IC(50) value was 172.2 ± 11.4 nM. Compound 51 could inhibit the activation of N...
Autores principales: | Yan, Yaoyao, Lv, Qi, Zhou, Feilong, Jian, Yujie, Xinhua, Liu, Chen, Xing, Hu, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10281321/ https://www.ncbi.nlm.nih.gov/pubmed/37325874 http://dx.doi.org/10.1080/14756366.2023.2225135 |
Ejemplares similares
-
Nanomembrane-driven co-elution and integration of active chemotherapeutic and anti-inflammatory agents
por: Pierstorff, Erik, et al.
Publicado: (2008) -
OXCT1 regulates NF-κB signaling pathway through β-hydroxybutyrate-mediated ketone body homeostasis in lung cancer
por: Lu, Zhuo, et al.
Publicado: (2022) -
Anti-inflammatory effects of intravenous methotrexate associated with lipid nanoemulsions on antigen-induced arthritis
por: Mello, Suzana B V, et al.
Publicado: (2016) -
Dehydrozaluzanin C, a novel type of anti-bacterial agent which targets transporting proteins, Opp and OpuC
por: Qin, Xiangyang, et al.
Publicado: (2021) -
VERITAS: Harnessing the power of nomenclature in biologic discovery
por: Biswas, Riti, et al.
Publicado: (2023)